Health Atlas
Menu
Evidence-led reference

Products & safety

Deodorants and antiperspirants: odor, sweat, aluminum, cancer evidence, and skin reactions

9 sources · Latest source check 2026-10-10 UTC
On this page

Deodorants target body odor; antiperspirants reduce sweat where applied. Products can combine these purposes. US regulation distinguishes cosmetic deodorant functions from sweat-reducing drug functions, so compare the product’s purpose before judging its ingredients.[1][2]

Different label features answer different questions

Different label features answer different questions
FeatureWhat it concerns
Deodorant functionOdor control as a cosmetic purpose.[1]
Antiperspirant functionReducing perspiration at the application site.[2]
Aluminum-based active ingredientA sweat-duct effect, distinct from perfume.[3]
Fragrance or essential oilScent and potential ingredient allergy, including plant-derived ingredients.[9]

A combined label can describe more than one purpose

FDA explains that the intended use determines whether a product is a cosmetic, a drug, or both. Its cosmetic examples include deodorants. This is a description of the legal framework, not a claim that every cosmetic or drug formulation has identical performance. When comparing underarm products, identify the stated function and complete label rather than assuming that a fragrance, an aluminum-free claim, and sweat reduction all mean the same thing.[1]

Why aluminum appears in antiperspirants

NCI explains that aluminum-based compounds form temporary plugs within sweat ducts, reducing the flow of sweat to the surface. This local mechanism is why an antiperspirant can reduce underarm wetness. It also explains why removing the antiperspirant active ingredient changes the comparison: an odor-control product may still be useful, but the ingredient claim alone does not demonstrate the same sweat-reduction function.[3]

Why another review can sound more concerned

A 2023 review found inconsistent results across six product-use studies and nonuniform findings in breast-tissue aluminum measurements. It described problems including retrospective designs, small cohorts, incomplete adjustment, and confusion between deodorants and antiperspirants. The authors nevertheless advised avoiding aluminum antiperspirants as a precaution, also considering cell studies. That precautionary recommendation is not the same finding as a demonstrated increase in cancer caused by normal product use. Cell effects and human disease outcomes require different interpretation.[6]

Absorption is measurable, but it is not a cancer outcome

A 2022 follow-up study used an aluminum tracer in a representative roll-on formulation in 12 healthy women. It estimated a very small absorbed fraction, about 0.00052%, and found that most of the applied aluminum remained associated with external skin layers. Several authors had industry affiliations. The study helps characterize exposure for its formulation and conditions; it does not measure lifetime cancer incidence, establish zero absorption, or provide a universal percentage for every product and skin condition.[7]

An exposure assessment has conditions and exclusions

The EU SCCS’s final March 2024 opinion considered aluminum compounds acceptable in specified cosmetic product categories at the stated maximum levels, with additional conditions for sprays. It excluded nano forms requiring a separate assessment and noted that high combined exposure from food and cosmetics could exceed safe limits. This is a conditional cosmetic-exposure assessment. It should not be summarized as every aluminum exposure is harmless, or confused with a brand-specific breast-cancer trial.[8]

A rash asks a different question from a cancer hypothesis

An older clinical review of deodorant and antiperspirant allergy discusses irritation, fragrance allergy, propylene glycol, and plant-derived essential oils. A rash can have different causes; merely switching to something described as natural does not identify or remove the responsible ingredient. The review describes clinical patch testing when an allergy needs investigation. Its old product survey is not a current market-wide ingredient census, but the distinction between irritation and ingredient allergy remains useful.[9]

The label is relevant to application site and skin comfort

FDA’s posted M019 antiperspirant monograph specifies underarm use and warnings about broken skin, rash or irritation, kidney disease, and avoiding inhalation of aerosol products. It also ties certain duration and extra-effectiveness claims to sweat-reduction testing. Such claims concern the defined performance outcome; they are not promises of complete dryness, freedom from irritation, or protection from every health risk. A different application site or formulation needs its own relevant instructions.[2]

Evidence & uncertainty

Human research has not established that underarm antiperspirants cause breast cancer. Findings and interpretations still differ: some review authors recommend aluminum avoidance on precautionary grounds, while current cancer information describes limited evidence for a causal link. Those positions should be read alongside the quality and type of the underlying studies.[4][6]

Selected-source overview · Independent review pending

Published questions

What is the difference between deodorant and antiperspirant?

Selected-source overview · Independent review pending. Read the evidence context.

Deodorant concerns odor control; antiperspirant concerns reducing sweat where it is applied. Products can combine both purposes. In the US these functions fall under different regulatory categories, so compare the stated function and active ingredients instead of assuming the words are interchangeable.[1][2]

Evidence behind this answer
  • Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)

    agency condition or prevention explanation · Date not stated
    Selected relevant original official page passages inspected · Original intended-use definitions, cosmetic examples including deodorants, and combined-function products

  • OTC Monograph M019: Antiperspirant Drug Products for Over-the-Counter Human Use

    agency condition or prevention explanation · 2021
    Original posted FDA monograph definition and labeling passages inspected directly; full subsequent order history, incorporated testing guidelines, and individual product compliance not independently appraised · Posted 2021-11-23; topical definition, labeling, warnings, and effectiveness-claim conditions

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Why do antiperspirants contain aluminum?

Selected-source overview · Independent review pending. Read the evidence context.

Aluminum-based active compounds produce temporary plugs in sweat ducts, reducing sweat reaching the surface. That is a local antiperspirant mechanism. An aluminum-free odor-control product should not automatically be assumed to provide the same reduction in wetness.[3]

Evidence behind this answer
  • Antiperspirants/Deodorants and Breast Cancer

    agency condition or prevention explanation · 2016
    Selected original fact-sheet mechanism passages and displayed 2016 review date inspected directly; newer cancer discussion uses separately dated sources · Page reviewed 2016-08-09; aluminum-based temporary sweat-duct plugs; date retained

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Do deodorants or antiperspirants cause breast cancer?

Selected-source overview · Independent review pending. Read the evidence context.

The ACS explanation revised in June 2026 describes mixed observational findings and limited evidence for that conclusion. It does not establish a causal link. Recall, product definitions, and study design matter; uncertainty should not be translated into either a proven cancer effect or a promise of perfect safety.[4]

Evidence behind this answer
  • Antiperspirants and Breast Cancer Risk

    professional association explanation · 2026
    Selected original cancer-organization explanation and displayed revision date inspected directly; underlying studies are not counted as independent evidence simply because cited in this explanation · Page revised 2026-06-26; observational cancer limitations, agency interpretation, and sweat/detoxification distinction

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does aluminum pass through the skin?

Selected-source overview · Independent review pending. Read the evidence context.

The selected tracer study estimated a small absorbed fraction under its tested conditions. That is different from saying none enters the body. A short exposure study cannot answer lifetime cancer risk, and its numerical result should not be transferred to every formulation or skin condition.[7]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Is natural deodorant automatically gentler?

Selected-source overview · Independent review pending. Read the evidence context.

No such guarantee follows from the label. The clinical allergy review identifies fragrances and plant-derived essential oils as potential allergens. Natural describes an ingredient’s origin or marketing, while tolerability depends on the actual formulation and the person’s response.[9]

Evidence behind this answer
  • Antiperspirant and deodorant allergy: diagnosis and management

    clinical narrative review · 2008
    Selected original indexed clinical-review passages and bibliographic record inspected; direct PMC was blocked and original journal returned 403; no full-text clinical appraisal or current product census · Original indexed journal/PMC passages; irritation, fragrance, propylene glycol, essential oils, patch testing and dated product survey

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a deodorant rash mean an aluminum allergy?

Selected-source overview · Independent review pending. Read the evidence context.

Not necessarily. Irritation and allergy to fragrance or another ingredient are different possibilities discussed in the clinical review. The rash alone does not identify its cause. Persistent or recurrent reactions can require an ingredient-focused clinical assessment, rather than repeated switches based only on marketing labels.[9]

Evidence behind this answer
  • Antiperspirant and deodorant allergy: diagnosis and management

    clinical narrative review · 2008
    Selected original indexed clinical-review passages and bibliographic record inspected; direct PMC was blocked and original journal returned 403; no full-text clinical appraisal or current product census · Original indexed journal/PMC passages; irritation, fragrance, propylene glycol, essential oils, patch testing and dated product survey

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does reducing underarm sweat trap toxins?

Selected-source overview · Independent review pending. Read the evidence context.

ACS explains that sweat glands mainly cool the body; kidneys and the liver handle removal of many unwanted substances. Reducing local sweat is therefore not evidence of blocked whole-body detoxification. A toxin-trapping claim needs actual exposure and health-outcome evidence.[4]

Evidence behind this answer
  • Antiperspirants and Breast Cancer Risk

    professional association explanation · 2026
    Selected original cancer-organization explanation and displayed revision date inspected directly; underlying studies are not counted as independent evidence simply because cited in this explanation · Page revised 2026-06-26; observational cancer limitations, agency interpretation, and sweat/detoxification distinction

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

What should I look for beyond an aluminum-free label?

Selected-source overview · Independent review pending. Read the evidence context.

Check whether the product promises odor control or sweat reduction, its application instructions, and relevant warnings. FDA’s posted antiperspirant monograph addresses underarm use, broken skin, irritation, kidney disease, and aerosol inhalation. Ingredient exclusions alone do not describe performance or suitability.[2]

Evidence behind this answer
  • OTC Monograph M019: Antiperspirant Drug Products for Over-the-Counter Human Use

    agency condition or prevention explanation · 2021
    Original posted FDA monograph definition and labeling passages inspected directly; full subsequent order history, incorporated testing guidelines, and individual product compliance not independently appraised · Posted 2021-11-23; topical definition, labeling, warnings, and effectiveness-claim conditions

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

The clinical cancer findings are mainly observational

A 2024 meta-analysis combined seven case-control studies. It found no overall association between underarm antiperspirant or deodorant use and breast cancer: the pooled odds ratio was 0.96, with a confidence interval from 0.78 to 1.17. The studies differed, and the authors called for prospective cohorts. This is evidence about observed cancer occurrence; it does not prove a precise zero effect, and retrospective exposure reports are different from randomized or carefully measured long-term exposure.[5]

References

  1. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)

    Agency condition or prevention explanation

    US Food and Drug Administration · Content/publication date: not stated
    Accessed: 2026-10-10 UTC · Selected relevant original official page passages inspected
    Cited sections: Original intended-use definitions, cosmetic examples including deodorants, and combined-function products

  2. OTC Monograph M019: Antiperspirant Drug Products for Over-the-Counter Human Use

    Agency condition or prevention explanation

    US Food and Drug Administration · Content/publication date: 2021
    Accessed: 2026-10-10 UTC · Original posted FDA monograph definition and labeling passages inspected directly; full subsequent order history, incorporated testing guidelines, and individual product compliance not independently appraised
    Cited sections: Posted 2021-11-23; topical definition, labeling, warnings, and effectiveness-claim conditions

  3. Antiperspirants/Deodorants and Breast Cancer

    Agency condition or prevention explanation

    National Cancer Institute · Content/publication date: 2016
    Accessed: 2026-10-10 UTC · Selected original fact-sheet mechanism passages and displayed 2016 review date inspected directly; newer cancer discussion uses separately dated sources
    Cited sections: Page reviewed 2016-08-09; aluminum-based temporary sweat-duct plugs; date retained

  4. Antiperspirants and Breast Cancer Risk

    Professional association explanation

    American Cancer Society medical and editorial content team · Content/publication date: 2026
    Accessed: 2026-10-10 UTC · Selected original cancer-organization explanation and displayed revision date inspected directly; underlying studies are not counted as independent evidence simply because cited in this explanation
    Cited sections: Page revised 2026-06-26; observational cancer limitations, agency interpretation, and sweat/detoxification distinction

  5. Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies

    Systematic review

    Trinh TTK, Myung SK, Tran TH, and Choi KS · Content/publication date: 2024
    Accessed: 2026-10-10 UTC · Original indexed review summary and selected methods/results inspected; no independent full-text appraisal
    Cited sections: Original indexed abstract; seven case-control studies, pooled association, heterogeneity, and call for prospective cohorts

  6. Correlation between daily life aluminium exposure and breast cancer risk: A systematic review

    Systematic review

    Moussaron A and colleagues · Content/publication date: 2023
    Accessed: 2026-10-10 UTC · Original review summary and selected methods/results inspected; no independent full-text appraisal
    Cited sections: Original abstract; search through 2022-11-18, inconsistent observations, tissue measurements, design limitations, and precautionary conclusion

  7. Assessment of dermal absorption of aluminium from a representative antiperspirant formulation using a (26Al)Al microtracer approach: a follow-up study in humans

    Human dermal exposure study

    de Ligt R and colleagues · Content/publication date: 2022
    Accessed: 2026-10-10 UTC · Original abstract and industry/nonindustry affiliations inspected directly; full exposure-model validation, funding and repeated-use clinical-outcome appraisal not independently completed
    Cited sections: Original abstract and affiliations; 12 healthy women, representative formulation, estimated absorption fraction and external-skin findings

  8. Safety of aluminium in cosmetic products - Submission IV

    Agency condition or prevention explanation

    European Commission Scientific Committee on Consumer Safety · Content/publication date: 2024
    Accessed: 2026-10-10 UTC · Original official final-opinion summary and adoption date inspected directly; full report tables, exposure calculations, complete later opinion history and product compliance not independently appraised
    Cited sections: Final opinion adopted 2024-03-27; conditional cosmetic uses, spray conditions, combined exposure and nano-form exclusion

  9. Antiperspirant and deodorant allergy: diagnosis and management

    Clinical narrative review

    Zirwas MJ and Moennich J · Content/publication date: 2008
    Accessed: 2026-10-10 UTC · Selected original indexed clinical-review passages and bibliographic record inspected; direct PMC was blocked and original journal returned 403; no full-text clinical appraisal or current product census
    Cited sections: Original indexed journal/PMC passages; irritation, fragrance, propylene glycol, essential oils, patch testing and dated product survey

Scope & review

Population
Everyday underarm-product users; source-specific women in observational cancer studies and a small dermal tracer study
Exposure or intervention
Odor-control deodorants, sweat-reducing antiperspirants, aluminum exposure, fragrance and other ingredient claims
Comparison
Source-specific alternative products and matched/control conditions
Outcomes
Local sweat reduction, odor-control distinctions, skin reactions, measured exposure, cancer observations, and label interpretation
Timeframe
Cancer explanation revised June 2026, explicitly dated research/reviews and EU opinion, and the FDA posted monograph; no brand verification
Jurisdiction
Selected US agency sources, dated professional guidance and original international research; jurisdiction and eligibility are source-specific

Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-10 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.

What this article still leaves open

  • No independent systematic synthesis or qualified clinical review has been completed.
  • Cancer sources share some underlying studies; mixed observational evidence and mechanistic hypotheses are not independent causal proof.
  • The small exposure study and conditional regulatory assessment do not establish lifetime clinical outcomes for every formulation.
  • Full subsequent monograph/opinion history, contemporary ingredient-allergy prevalence and individual product compliance remain outside this selected-source review.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.